Lundbeck
HLUN-B.CO
#2442
Rank
A$9.28 B
Marketcap
$9.73
Share price
0.62%
Change (1 day)
31.47%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

Earnings for Lundbeck (HLUN-B.CO)

Earnings in 2024 (TTM): A$0.71 Billion

According to Lundbeck 's latest financial reports the company's current earnings are A$2.98 Billion. In 2023 the company made an earning of A$0.67 Billion, an increase over its 2022 earnings that were of A$0.55 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lundbeck from 2009 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) A$0.71 B5.17%
2023 A$0.67 B21.69%
2022 A$0.55 B31.79%
2021 A$0.42 B-4.53%
2020 A$0.44 B-45.08%
2019 A$0.80 B-33.97%
2018 A$1.22 B12.76%
2017 A$1.08 B94.32%
2016 A$0.55 B-136.98%
2015 -A$1.51 Billion-1258.1%
2014 A$0.13 B-72.43%
2013 A$0.47 B4.31%
2012 A$0.45 B-55.26%
2011 A$1.01 B6.64%
2010 A$0.94 B-6.68%
2009 A$1.01 B